| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Interleukin-1 Receptor Accessory Protein | 1 | 2023 | 3 | 0.790 |
Why?
|
| Drug Delivery Systems | 1 | 2023 | 12 | 0.780 |
Why?
|
| Recreation | 1 | 2020 | 1 | 0.660 |
Why?
|
| Contact Tracing | 1 | 2020 | 4 | 0.660 |
Why?
|
| Music | 1 | 2020 | 2 | 0.660 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 20 | 0.640 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 19 | 0.640 |
Why?
|
| Otitis Media | 8 | 2006 | 9 | 0.550 |
Why?
|
| Animals | 33 | 2026 | 1875 | 0.550 |
Why?
|
| Humans | 37 | 2026 | 6794 | 0.360 |
Why?
|
| Haemophilus influenzae | 6 | 2008 | 6 | 0.350 |
Why?
|
| Ear, Middle | 6 | 2008 | 6 | 0.310 |
Why?
|
| beta-Defensins | 5 | 2008 | 5 | 0.270 |
Why?
|
| Neurofibromatosis 2 | 4 | 2015 | 4 | 0.260 |
Why?
|
| Neuroma, Acoustic | 3 | 2015 | 3 | 0.250 |
Why?
|
| Epithelial Cells | 8 | 2014 | 49 | 0.250 |
Why?
|
| Furans | 1 | 2026 | 9 | 0.240 |
Why?
|
| Lignans | 1 | 2026 | 9 | 0.240 |
Why?
|
| DNA | 4 | 2023 | 39 | 0.240 |
Why?
|
| Eustachian Tube | 2 | 2007 | 2 | 0.240 |
Why?
|
| Mice | 15 | 2026 | 746 | 0.230 |
Why?
|
| Lipoproteins, LDL | 6 | 1994 | 9 | 0.220 |
Why?
|
| Simian Immunodeficiency Virus | 1 | 2024 | 1 | 0.220 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2024 | 1 | 0.220 |
Why?
|
| Macaca mulatta | 1 | 2024 | 8 | 0.220 |
Why?
|
| Genetic Vectors | 1 | 2024 | 19 | 0.220 |
Why?
|
| Child | 4 | 2020 | 524 | 0.220 |
Why?
|
| Viremia | 1 | 2024 | 8 | 0.220 |
Why?
|
| Transcriptome | 2 | 2015 | 31 | 0.210 |
Why?
|
| Breast Neoplasms | 1 | 2026 | 170 | 0.210 |
Why?
|
| Membrane Glycoproteins | 2 | 2021 | 65 | 0.210 |
Why?
|
| Gene Expression Regulation | 7 | 2008 | 120 | 0.200 |
Why?
|
| Female | 11 | 2026 | 4060 | 0.200 |
Why?
|
| Infant | 2 | 2020 | 187 | 0.200 |
Why?
|
| Drug Discovery | 1 | 2023 | 1 | 0.200 |
Why?
|
| Mice, Inbred Strains | 4 | 2006 | 21 | 0.190 |
Why?
|
| Child, Preschool | 2 | 2020 | 258 | 0.190 |
Why?
|
| Universities | 1 | 2023 | 21 | 0.190 |
Why?
|
| Adult | 6 | 2020 | 2113 | 0.190 |
Why?
|
| Alphavirus | 1 | 2022 | 1 | 0.180 |
Why?
|
| Male | 9 | 2020 | 3671 | 0.180 |
Why?
|
| Adolescent | 3 | 2020 | 869 | 0.180 |
Why?
|
| Multigene Family | 2 | 1993 | 6 | 0.180 |
Why?
|
| Virus Attachment | 1 | 2021 | 1 | 0.170 |
Why?
|
| Middle Aged | 5 | 2020 | 2108 | 0.170 |
Why?
|
| Tympanic Membrane | 1 | 2000 | 3 | 0.170 |
Why?
|
| Japan | 1 | 2020 | 6 | 0.170 |
Why?
|
| Young Adult | 2 | 2020 | 567 | 0.160 |
Why?
|
| Betacoronavirus | 1 | 2020 | 14 | 0.160 |
Why?
|
| Arteriosclerosis | 4 | 1995 | 10 | 0.160 |
Why?
|
| Immunity, Innate | 4 | 2021 | 20 | 0.160 |
Why?
|
| NF-kappa B | 4 | 1994 | 56 | 0.160 |
Why?
|
| Signal Transduction | 6 | 2014 | 246 | 0.150 |
Why?
|
| Pandemics | 1 | 2020 | 87 | 0.150 |
Why?
|
| Toll-Like Receptor 2 | 3 | 2008 | 12 | 0.140 |
Why?
|
| Rats | 8 | 2014 | 571 | 0.140 |
Why?
|
| Inflammation | 5 | 2005 | 143 | 0.130 |
Why?
|
| Up-Regulation | 6 | 2008 | 94 | 0.130 |
Why?
|
| Inflammation Mediators | 3 | 2006 | 30 | 0.130 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2007 | 18 | 0.130 |
Why?
|
| Mucins | 4 | 2021 | 5 | 0.120 |
Why?
|
| RNA, Messenger | 10 | 2008 | 190 | 0.120 |
Why?
|
| Minocycline | 1 | 2016 | 1 | 0.120 |
Why?
|
| Osteoprotegerin | 1 | 2016 | 1 | 0.120 |
Why?
|
| Albumins | 1 | 2016 | 10 | 0.120 |
Why?
|
| HIV Infections | 1 | 2021 | 432 | 0.120 |
Why?
|
| Interleukin-6 | 1 | 2016 | 45 | 0.120 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 5 | 2008 | 21 | 0.120 |
Why?
|
| Diabetic Nephropathies | 1 | 2016 | 56 | 0.120 |
Why?
|
| Janus Kinases | 1 | 2014 | 3 | 0.110 |
Why?
|
| Peritoneum | 1 | 2014 | 4 | 0.110 |
Why?
|
| STAT1 Transcription Factor | 1 | 2014 | 6 | 0.110 |
Why?
|
| Peritonitis | 1 | 2014 | 3 | 0.110 |
Why?
|
| Aquaporins | 2 | 2007 | 11 | 0.110 |
Why?
|
| Dialysis Solutions | 1 | 2014 | 7 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-raf | 2 | 2006 | 2 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 1 | 2014 | 16 | 0.110 |
Why?
|
| Gene Expression Profiling | 3 | 2014 | 44 | 0.110 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 51 | 0.100 |
Why?
|
| Antibodies, Neutralizing | 2 | 2024 | 9 | 0.100 |
Why?
|
| Dimethylallyltranstransferase | 1 | 1993 | 1 | 0.100 |
Why?
|
| Muridae | 1 | 1993 | 1 | 0.100 |
Why?
|
| Muramidase | 2 | 2004 | 4 | 0.100 |
Why?
|
| Endothelium, Vascular | 4 | 1994 | 30 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2002 | 10 | 0.090 |
Why?
|
| Mucous Membrane | 3 | 2007 | 5 | 0.090 |
Why?
|
| Cytokines | 3 | 2005 | 80 | 0.090 |
Why?
|
| Interleukin-1 | 3 | 2006 | 12 | 0.090 |
Why?
|
| Genes | 1 | 1989 | 2 | 0.080 |
Why?
|
| Lipase | 1 | 1989 | 10 | 0.080 |
Why?
|
| Pneumococcal Infections | 2 | 2007 | 2 | 0.080 |
Why?
|
| Lipoprotein Lipase | 1 | 1989 | 6 | 0.080 |
Why?
|
| Cell Line | 6 | 2008 | 124 | 0.080 |
Why?
|
| Biological Evolution | 1 | 1989 | 17 | 0.080 |
Why?
|
| Cells, Cultured | 6 | 2014 | 234 | 0.080 |
Why?
|
| Cell Movement | 2 | 2026 | 38 | 0.080 |
Why?
|
| Chromosome Mapping | 4 | 2006 | 10 | 0.080 |
Why?
|
| Ear Neoplasms | 1 | 2008 | 1 | 0.070 |
Why?
|
| Vestibule, Labyrinth | 1 | 2008 | 1 | 0.070 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2008 | 11 | 0.070 |
Why?
|
| Receptors, Progesterone | 1 | 2008 | 11 | 0.070 |
Why?
|
| Streptococcus pneumoniae | 2 | 2007 | 2 | 0.070 |
Why?
|
| Receptors, Estrogen | 1 | 2008 | 32 | 0.070 |
Why?
|
| HeLa Cells | 3 | 2021 | 15 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 2 | 2005 | 11 | 0.070 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 2008 | 1 | 0.070 |
Why?
|
| Genes, erbB | 1 | 2008 | 1 | 0.070 |
Why?
|
| Neuregulins | 1 | 2008 | 1 | 0.070 |
Why?
|
| Growth Substances | 4 | 2005 | 10 | 0.070 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2007 | 1 | 0.070 |
Why?
|
| Cysteine Endopeptidases | 1 | 2007 | 13 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 72 | 0.060 |
Why?
|
| Simian virus 40 | 1 | 2006 | 1 | 0.060 |
Why?
|
| Cochlea | 1 | 2006 | 3 | 0.060 |
Why?
|
| Adenoviridae | 1 | 2006 | 8 | 0.060 |
Why?
|
| Bacterial Proteins | 2 | 2007 | 10 | 0.060 |
Why?
|
| Haemophilus Infections | 1 | 2006 | 1 | 0.060 |
Why?
|
| Organ of Corti | 1 | 2006 | 1 | 0.060 |
Why?
|
| Spiral Lamina | 1 | 2006 | 1 | 0.060 |
Why?
|
| Spiral Ganglion | 1 | 2006 | 2 | 0.060 |
Why?
|
| Chemokines | 1 | 2006 | 11 | 0.060 |
Why?
|
| MCF-7 Cells | 1 | 2026 | 15 | 0.060 |
Why?
|
| Mice, SCID | 1 | 2026 | 16 | 0.060 |
Why?
|
| Rabbits | 4 | 2000 | 48 | 0.060 |
Why?
|
| Neurofibromin 2 | 1 | 2006 | 1 | 0.060 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2006 | 2 | 0.060 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2026 | 38 | 0.060 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2006 | 7 | 0.060 |
Why?
|
| Lung | 1 | 2007 | 106 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 63 | 0.060 |
Why?
|
| Chemotactic Factors | 3 | 1994 | 3 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2026 | 156 | 0.060 |
Why?
|
| ErbB Receptors | 1 | 2005 | 13 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2026 | 88 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2006 | 231 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2026 | 143 | 0.060 |
Why?
|
| Diagnostic Techniques, Otological | 1 | 2005 | 1 | 0.060 |
Why?
|
| Otitis Media with Effusion | 1 | 2005 | 1 | 0.060 |
Why?
|
| Ear, Inner | 1 | 2005 | 2 | 0.060 |
Why?
|
| Apoptosis | 1 | 2026 | 179 | 0.050 |
Why?
|
| Gene Products, rev | 1 | 2024 | 1 | 0.050 |
Why?
|
| Lentivirus | 1 | 2024 | 1 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2024 | 14 | 0.050 |
Why?
|
| Viral Load | 1 | 2024 | 26 | 0.050 |
Why?
|
| Chemokines, CXC | 2 | 1994 | 4 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 5 | 2008 | 258 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 1994 | 14 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 2 | 2014 | 6 | 0.050 |
Why?
|
| Mass Screening | 1 | 2005 | 116 | 0.050 |
Why?
|
| Transcription, Genetic | 3 | 1993 | 40 | 0.050 |
Why?
|
| Genetic Markers | 3 | 2006 | 7 | 0.050 |
Why?
|
| Crosses, Genetic | 3 | 2006 | 6 | 0.050 |
Why?
|
| Diet, Atherogenic | 2 | 1993 | 3 | 0.050 |
Why?
|
| Chemokine CCL2 | 3 | 2014 | 12 | 0.050 |
Why?
|
| Monocytes | 3 | 2006 | 14 | 0.050 |
Why?
|
| Disease Susceptibility | 2 | 2000 | 10 | 0.050 |
Why?
|
| Gene Expression | 3 | 2006 | 77 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2002 | 5 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2002 | 7 | 0.050 |
Why?
|
| Porins | 1 | 2002 | 1 | 0.050 |
Why?
|
| I-kappa B Proteins | 1 | 2002 | 4 | 0.050 |
Why?
|
| Drosophila Proteins | 1 | 2002 | 9 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 29 | 0.050 |
Why?
|
| Antiviral Agents | 1 | 2022 | 53 | 0.050 |
Why?
|
| Immunohistochemistry | 3 | 2008 | 118 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2002 | 65 | 0.040 |
Why?
|
| Mice, Congenic | 1 | 2001 | 1 | 0.040 |
Why?
|
| Molecular Sequence Data | 5 | 1994 | 70 | 0.040 |
Why?
|
| Genome | 1 | 2001 | 7 | 0.040 |
Why?
|
| Madin Darby Canine Kidney Cells | 1 | 2021 | 1 | 0.040 |
Why?
|
| Dogs | 1 | 2021 | 18 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 16 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 3 | 2008 | 43 | 0.040 |
Why?
|
| Lactoferrin | 1 | 2000 | 1 | 0.040 |
Why?
|
| Mucus | 1 | 2000 | 1 | 0.040 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2000 | 1 | 0.040 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 1 | 2000 | 1 | 0.040 |
Why?
|
| Pulmonary Surfactant-Associated Proteins | 1 | 2000 | 3 | 0.040 |
Why?
|
| HIV-1 | 1 | 2021 | 36 | 0.040 |
Why?
|
| Cilia | 1 | 2000 | 5 | 0.040 |
Why?
|
| Proteolipids | 1 | 2000 | 2 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2000 | 10 | 0.040 |
Why?
|
| Pulmonary Surfactants | 1 | 2000 | 9 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2007 | 90 | 0.040 |
Why?
|
| Blotting, Western | 3 | 2007 | 110 | 0.040 |
Why?
|
| Homeostasis | 1 | 2000 | 40 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2014 | 73 | 0.040 |
Why?
|
| Hybridization, Genetic | 2 | 2006 | 2 | 0.040 |
Why?
|
| Genetic Linkage | 2 | 2006 | 4 | 0.040 |
Why?
|
| Polymorphism, Genetic | 2 | 2006 | 9 | 0.040 |
Why?
|
| Oocytes | 1 | 2000 | 9 | 0.040 |
Why?
|
| Time Factors | 2 | 2014 | 321 | 0.040 |
Why?
|
| Amino Acid Sequence | 4 | 1994 | 38 | 0.040 |
Why?
|
| Models, Biological | 3 | 2005 | 64 | 0.040 |
Why?
|
| Base Sequence | 4 | 1993 | 65 | 0.040 |
Why?
|
| Proteins | 2 | 2016 | 41 | 0.040 |
Why?
|
| Mutation | 2 | 2006 | 97 | 0.030 |
Why?
|
| Cell Adhesion | 4 | 2005 | 19 | 0.030 |
Why?
|
| Lipid Peroxidation | 2 | 1994 | 11 | 0.030 |
Why?
|
| Rats, Inbred WKY | 2 | 2007 | 2 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 35 | 0.030 |
Why?
|
| Monocyte Chemoattractant Proteins | 2 | 1993 | 2 | 0.030 |
Why?
|
| MAP Kinase Kinase 3 | 2 | 2007 | 3 | 0.030 |
Why?
|
| Aged | 2 | 2014 | 1539 | 0.030 |
Why?
|
| Fibroblasts | 2 | 2007 | 53 | 0.030 |
Why?
|
| Placebo Effect | 1 | 2016 | 5 | 0.030 |
Why?
|
| DNA-Binding Proteins | 2 | 2002 | 38 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2016 | 89 | 0.030 |
Why?
|
| Creatinine | 1 | 2016 | 48 | 0.030 |
Why?
|
| Cricetinae | 2 | 1993 | 11 | 0.030 |
Why?
|
| Arteritis | 1 | 1995 | 1 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2016 | 331 | 0.030 |
Why?
|
| Lipids | 1 | 1995 | 35 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2015 | 19 | 0.030 |
Why?
|
| Serum Amyloid A Protein | 1 | 1994 | 2 | 0.030 |
Why?
|
| Peritoneal Fibrosis | 1 | 2014 | 1 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2014 | 6 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 17 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2014 | 11 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2014 | 27 | 0.030 |
Why?
|
| Nitriles | 1 | 2014 | 13 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 12 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 3 | 2005 | 46 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2014 | 17 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2014 | 23 | 0.030 |
Why?
|
| src-Family Kinases | 2 | 2005 | 7 | 0.030 |
Why?
|
| Genotype | 2 | 2006 | 28 | 0.030 |
Why?
|
| Transfection | 2 | 2005 | 56 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2016 | 500 | 0.030 |
Why?
|
| Exons | 2 | 1993 | 8 | 0.030 |
Why?
|
| Peritoneal Dialysis | 1 | 2014 | 48 | 0.030 |
Why?
|
| Age Factors | 1 | 2014 | 193 | 0.030 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 2 | 1990 | 2 | 0.030 |
Why?
|
| Leukocytes | 1 | 1993 | 9 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 1993 | 30 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 1993 | 22 | 0.020 |
Why?
|
| Oxidation-Reduction | 4 | 1993 | 19 | 0.020 |
Why?
|
| Phenotype | 2 | 2006 | 91 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1989 | 5 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1993 | 1 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 1993 | 1 | 0.020 |
Why?
|
| Hybrid Cells | 1 | 1993 | 4 | 0.020 |
Why?
|
| Pseudogenes | 1 | 1993 | 2 | 0.020 |
Why?
|
| Hydroxycholesterols | 1 | 1990 | 2 | 0.020 |
Why?
|
| Fatty Acids | 1 | 1990 | 25 | 0.020 |
Why?
|
| Colony-Stimulating Factors | 1 | 1990 | 1 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 1992 | 208 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1989 | 3 | 0.020 |
Why?
|
| Gene Library | 1 | 1989 | 2 | 0.020 |
Why?
|
| Sterols | 1 | 1989 | 1 | 0.020 |
Why?
|
| Metalloproteins | 1 | 1989 | 2 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1989 | 7 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 1989 | 11 | 0.020 |
Why?
|
| Lipopolysaccharides | 2 | 2002 | 41 | 0.020 |
Why?
|
| Vestibular Nerve | 1 | 2008 | 1 | 0.020 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2008 | 1 | 0.020 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2008 | 2 | 0.020 |
Why?
|
| Macrophage Colony-Stimulating Factor | 3 | 1993 | 5 | 0.020 |
Why?
|
| Tissue Banks | 1 | 2008 | 1 | 0.020 |
Why?
|
| Ligands | 1 | 2008 | 17 | 0.020 |
Why?
|
| RNA | 1 | 2008 | 25 | 0.020 |
Why?
|
| Deubiquitinating Enzyme CYLD | 1 | 2007 | 1 | 0.020 |
Why?
|
| Serpin E2 | 1 | 2007 | 1 | 0.020 |
Why?
|
| Streptolysins | 1 | 2007 | 2 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 10 | 0.020 |
Why?
|
| Serpins | 1 | 2007 | 5 | 0.020 |
Why?
|
| Basement Membrane | 1 | 2007 | 11 | 0.020 |
Why?
|
| Aging | 1 | 2008 | 105 | 0.020 |
Why?
|
| Connexins | 1 | 2006 | 1 | 0.020 |
Why?
|
| Vimentin | 1 | 2006 | 2 | 0.020 |
Why?
|
| Cell Transformation, Viral | 1 | 2006 | 4 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2006 | 8 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2006 | 18 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2006 | 2 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2006 | 9 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2006 | 5 | 0.020 |
Why?
|
| Genetic Techniques | 1 | 2006 | 1 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2006 | 1 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2006 | 3 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 11 | 0.020 |
Why?
|
| Multienzyme Complexes | 1 | 2006 | 12 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2006 | 39 | 0.020 |
Why?
|
| MAP Kinase Kinase 6 | 1 | 2005 | 2 | 0.010 |
Why?
|
| Plasmids | 1 | 2005 | 17 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2005 | 8 | 0.010 |
Why?
|
| RNA Interference | 1 | 2005 | 11 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 12 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2006 | 39 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 45 | 0.010 |
Why?
|
| Immune System | 1 | 2005 | 14 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2005 | 57 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2008 | 681 | 0.010 |
Why?
|
| Hearing Loss, Conductive | 1 | 2005 | 1 | 0.010 |
Why?
|
| Cholesteatoma, Middle Ear | 1 | 2005 | 1 | 0.010 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2005 | 3 | 0.010 |
Why?
|
| Temporal Bone | 1 | 2005 | 2 | 0.010 |
Why?
|
| Genome, Bacterial | 1 | 2005 | 4 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2005 | 7 | 0.010 |
Why?
|
| Bacterial Vaccines | 1 | 2005 | 3 | 0.010 |
Why?
|
| Models, Animal | 1 | 2005 | 23 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2005 | 101 | 0.010 |
Why?
|
| Health Personnel | 1 | 2005 | 49 | 0.010 |
Why?
|
| Caregivers | 1 | 2005 | 29 | 0.010 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2004 | 10 | 0.010 |
Why?
|
| Parents | 1 | 2005 | 42 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2004 | 10 | 0.010 |
Why?
|
| Anti-Infective Agents | 1 | 2004 | 9 | 0.010 |
Why?
|
| Transcriptional Activation | 2 | 1994 | 9 | 0.010 |
Why?
|
| Mice, Inbred C3H | 2 | 1994 | 39 | 0.010 |
Why?
|
| Chemokine CXCL1 | 2 | 1994 | 4 | 0.010 |
Why?
|
| Liver | 2 | 1994 | 157 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2002 | 1 | 0.010 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2002 | 1 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 48 | 0.010 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2002 | 3 | 0.010 |
Why?
|
| Rodentia | 1 | 2002 | 4 | 0.010 |
Why?
|
| Protein Transport | 1 | 2002 | 23 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2002 | 16 | 0.010 |
Why?
|
| Aorta | 2 | 1993 | 20 | 0.010 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2001 | 1 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2001 | 2 | 0.010 |
Why?
|
| Chromosomes | 1 | 2001 | 4 | 0.010 |
Why?
|
| Kinetics | 2 | 1990 | 69 | 0.010 |
Why?
|
| Molecular Probe Techniques | 1 | 2000 | 1 | 0.010 |
Why?
|
| Expressed Sequence Tags | 1 | 2000 | 2 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2000 | 8 | 0.010 |
Why?
|
| DNA Probes | 2 | 1990 | 5 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2000 | 81 | 0.010 |
Why?
|
| United States | 1 | 2000 | 1019 | 0.010 |
Why?
|
| Arteries | 1 | 1995 | 15 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 1995 | 33 | 0.010 |
Why?
|
| Heparin | 1 | 1994 | 8 | 0.010 |
Why?
|
| Apolipoproteins A | 1 | 1994 | 1 | 0.010 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 1994 | 3 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 1995 | 102 | 0.010 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 1993 | 1 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 4 | 0.010 |
Why?
|
| Second Messenger Systems | 1 | 1993 | 6 | 0.010 |
Why?
|
| Enzymes | 1 | 1993 | 5 | 0.010 |
Why?
|
| Species Specificity | 1 | 1993 | 17 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1993 | 72 | 0.010 |
Why?
|
| L-Selectin | 1 | 1993 | 1 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1993 | 2 | 0.010 |
Why?
|
| Endothelium | 1 | 1993 | 4 | 0.010 |
Why?
|
| Sterol O-Acyltransferase | 1 | 1990 | 1 | 0.010 |
Why?
|
| Enzyme Repression | 1 | 1990 | 1 | 0.010 |
Why?
|
| Inositol | 1 | 1990 | 1 | 0.010 |
Why?
|
| Aphidicolin | 1 | 1990 | 1 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 1990 | 2 | 0.010 |
Why?
|
| Diterpenes | 1 | 1990 | 2 | 0.010 |
Why?
|
| Cricetulus | 1 | 1990 | 6 | 0.010 |
Why?
|
| Acetates | 1 | 1990 | 6 | 0.010 |
Why?
|
| Cell Division | 1 | 1990 | 40 | 0.010 |
Why?
|
| Drug Resistance | 1 | 1990 | 16 | 0.010 |
Why?
|
| Ovary | 1 | 1990 | 19 | 0.010 |
Why?
|
| Ferrous Compounds | 1 | 1990 | 1 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1990 | 5 | 0.010 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 1990 | 2 | 0.010 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1990 | 5 | 0.010 |
Why?
|
| Receptors, LDL | 1 | 1989 | 6 | 0.000 |
Why?
|
| Binding Sites | 1 | 1989 | 24 | 0.000 |
Why?
|
| Tumor Cells, Cultured | 1 | 1989 | 72 | 0.000 |
Why?
|
| Promoter Regions, Genetic | 1 | 1989 | 45 | 0.000 |
Why?
|
| Cholesterol | 1 | 1989 | 37 | 0.000 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1989 | 34 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 1989 | 63 | 0.000 |
Why?
|